Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xphyto Therapeutics Corp (XPHY.CN)

Xphyto Therapeutics Corp (XPHY.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 43,734
  • Shares Outstanding, K 79,517
  • Annual Sales, $ 286 K
  • Annual Income, $ -20,637 K
  • 60-Month Beta N/A
  • Price/Sales 99.84
  • Price/Cash Flow N/A
  • Price/Book 24.09
Trade XPHY.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.23
  • Most Recent Earnings -0.02 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.500 +8.00%
on 06/23/22
0.800 -32.50%
on 05/31/22
-0.260 (-32.50%)
since 05/27/22
3-Month
0.500 +8.00%
on 06/23/22
1.060 -49.06%
on 04/22/22
-0.310 (-36.47%)
since 03/30/22
52-Week
0.500 +8.00%
on 06/23/22
2.000 -73.00%
on 08/13/21
-1.150 (-68.05%)
since 06/30/21

Most Recent Stories

More News
XPhyto, Biosensors Market and Product Developments on Platform-Based Oral Dissolvable Biosensors for Oral Health and Infectious Disease

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / April 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a market and product...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Completes Transformative Step in Commercial Strategy with 3a Acquisition

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities,...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH

- The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology - The acquisition of 3a, a German-based rapid point-of-care...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
XPhyto Therapeutics Announces Stock Option Grants

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 26, 2021 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Appoints New CFO

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has named a new chief financial officer: Joseph Meagher. A chartered...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
XPhyto Announces CFO Appointment

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
DTC.CN : 2.000 (unch)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 0.8600 (-0.77%)
ATNM : 4.91 (-1.21%)
ADCO.TO : 0.1750 (-2.78%)
ADCOF : 0.1590 (+4.88%)
ALIM : 5.50 (-3.51%)
ACOGF : 0.3865 (+0.39%)
AMST : 0.4700 (-2.08%)
ANVS : 11.22 (-2.26%)
ANPC : 0.3203 (+6.77%)
ARC : 2.62 (-0.76%)
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including:...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT)...

XPHY.CN : 0.540 (-1.82%)
XPHYF : 0.4102 (-4.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.583
2nd Resistance Point 0.577
1st Resistance Point 0.563
Last Price 0.540
1st Support Level 0.543
2nd Support Level 0.537
3rd Support Level 0.523

See More

52-Week High 2.000
Fibonacci 61.8% 1.427
Fibonacci 50% 1.250
Fibonacci 38.2% 1.073
Last Price 0.540
52-Week Low 0.500

See More

Business Summary

XPhyto Therapeutics Corp is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar